Advalight Welcomes Amogh Kothare As New Chief Scientific Officer

2023-11-20
高管变更
LOS ANGELES, Nov. 20, 2023 /PRNewswire/ -- Advalight, the globally renowned company behind ADVATx, the sophisticated dual 589nm and 1319nm wavelength solid-state laser, announces the appointment of Amogh Kothare as Chief Scientific Officer.
As a biomedical engineer, Kothare brings nearly 20 years of experience in the aesthetic laser industry and has been an integral part of the development of cutting-edge devices.
Continue Reading
Advalight, the globally renowned company, announces the appointment of Amogh Kothare as Chief Scientific Officer.
Post this
Advalight Welcomes Amogh Kothare As New Chief Scientific Officer
Preview
来源: PRNewswire
Advalight Welcomes Amogh Kothare As New Chief Scientific Officer
In this role, Kothare will be globally responsible for clinical research, partnerships, product management, and clinical affairs and training, to further leverage Advalight's scientific approach to innovation.
"Under Amogh's scientific and clinical leadership, we intend to strengthen and expand our clinical research partnerships with leading physicians in the U.S. and globally," said Jacob L. Philipsen, CEO of Advalight. "We firmly believe that Amogh's industry insight and deep understanding of user and patient needs, combined with our world-class engineering team, will take our product offerings and thereby our company to the next level and beyond."
Prior to joining Advalight, Kothare served in a similar role at Cutera, one of the global leaders of the aesthetic laser industry where he spearheaded the development and launch of a series of innovative products.
"I have been a part of the aesthetic industry for almost two decades and was really impressed with Advalight's pioneering technology, and their desire to put science and technology at the forefront of their product development efforts," Kothare said. "I am grateful to be a part of this team, and I look forward to collectively making Advalight the next big thing in aesthetics and medical dermatology."
President of Advalight Corp., Travis Mahan, is keen to incorporate Kothare's unique combination of engineering expertise and organizational best practices to accelerate the exponential growth the company has experienced over the past several years.
"Adding Amogh to lead our talented team of engineers is an exciting leap forward in the evolution of Advalight, both from a future product development standpoint, and for the continuing optimization of the current ADVATx platform," Mahan said. "I'm personally beyond excited and grateful to welcome Amogh to the Advalight family."
About Advalight:
Founded in 2006, Advalight is the company behind the groundbreaking dual wavelength ADVATx. Headquartered in Copenhagen, Denmark, with sales and service offices in San Diego, CA, USA, ADVATx is available to dermatological and aesthetic practices in over 30 countries through our network of global distributors.
SOURCE ADVATx
更多内容,请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
适应症
-
靶点
-
药物
-
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。